118 related articles for article (PubMed ID: 29434894)
1. Down-expression of poly(ADP-ribose) polymerase in p53-regulated pancreatic cancer cells.
Hou Z; Cui Y; Xing H; Mu X
Oncol Lett; 2018 Feb; 15(2):1943-1948. PubMed ID: 29434894
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) polymerase inhibitors activate the p53 signaling pathway in neural stem/progenitor cells.
Okuda A; Kurokawa S; Takehashi M; Maeda A; Fukuda K; Kubo Y; Nogusa H; Takatani-Nakase T; Okuda S; Ueda K; Tanaka S
BMC Neurosci; 2017 Jan; 18(1):14. PubMed ID: 28095779
[TBL] [Abstract][Full Text] [Related]
3. Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1.
Yoon JH; Ahn SG; Lee BH; Jung SH; Oh SH
Biochem Pharmacol; 2012 Mar; 83(6):747-57. PubMed ID: 22226932
[TBL] [Abstract][Full Text] [Related]
4. 53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells.
Hong R; Ma F; Zhang W; Yu X; Li Q; Luo Y; Zhu C; Jiang W; Xu B
BMC Cancer; 2016 Sep; 16(1):725. PubMed ID: 27613518
[TBL] [Abstract][Full Text] [Related]
5. Macamide B suppresses lung cancer progression potentially via the ATM signaling pathway.
Tao H; Shi H; Wang M; Xu Y
Oncol Lett; 2023 Mar; 25(3):115. PubMed ID: 36844627
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress induces apoptosis via calpain- and caspase-3-mediated cleavage of ATM in pancreatic acinar cells.
Cho SO; Lim JW; Kim H
Free Radic Res; 2020 Dec; 54(11-12):799-809. PubMed ID: 31401888
[TBL] [Abstract][Full Text] [Related]
7. ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib.
Wang C; Jette N; Moussienko D; Bebb DG; Lees-Miller SP
Transl Oncol; 2017 Apr; 10(2):190-196. PubMed ID: 28182994
[TBL] [Abstract][Full Text] [Related]
8. Interactions Between Ataxia Telangiectasia Mutated Kinase Inhibition, Poly(ADP-ribose) Polymerase-1 Inhibition and BRCA1 Status in Breast Cancer Cells.
Węsierska-Gądek J; Heinzl S
J Cancer Prev; 2014 Jun; 19(2):125-36. PubMed ID: 25337581
[TBL] [Abstract][Full Text] [Related]
9. PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis.
Muñoz-Gámez JA; Martín-Oliva D; Aguilar-Quesada R; Cañuelo A; Nuñez MI; Valenzuela MT; Ruiz de Almodóvar JM; De Murcia G; Oliver FJ
Biochem J; 2005 Feb; 386(Pt 1):119-25. PubMed ID: 15456408
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymerase suppression protects rheumatoid synovial fibroblasts from Fas-induced apoptosis.
García S; Mera A; Gómez-Reino JJ; Conde C
Rheumatology (Oxford); 2009 May; 48(5):483-9. PubMed ID: 19228791
[TBL] [Abstract][Full Text] [Related]
11. Nicotinamide- and caspase-mediated inhibition of poly(ADP-ribose) polymerase are associated with p53-independent cell cycle (G2) arrest and apoptosis.
Saldeen J; Tillmar L; Karlsson E; Welsh N
Mol Cell Biochem; 2003 Jan; 243(1-2):113-22. PubMed ID: 12619896
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells.
Min A; Im SA; Kim DK; Song SH; Kim HJ; Lee KH; Kim TY; Han SW; Oh DY; Kim TY; O'Connor MJ; Bang YJ
Breast Cancer Res; 2015 Mar; 17():33. PubMed ID: 25888415
[TBL] [Abstract][Full Text] [Related]
13. Ca(2+)-calmodulin antagonist chlorpromazine and poly(ADP-ribose) polymerase modulators 4-aminobenzamide and nicotinamide influence hepatic expression of BCL-XL and P53 and protect against acetaminophen-induced programmed and unprogrammed cell death in mice.
Ray SD; Balasubramanian G; Bagchi D; Reddy CS
Free Radic Biol Med; 2001 Aug; 31(3):277-91. PubMed ID: 11461765
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of poly(ADP-ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM) on the chemosensitivity of mantle cell lymphoma to agents that induce DNA strand breaks.
Golla RM; Li M; Shen Y; Ji M; Yan Y; Fu K; Greiner TC; McKeithan TW; Chan WC
Hematol Oncol; 2012 Dec; 30(4):175-9. PubMed ID: 22170260
[TBL] [Abstract][Full Text] [Related]
15. Xanthohumol inhibits proliferation of laryngeal squamous cell carcinoma.
Li Y; Wang K; Yin S; Zheng H; Min D
Oncol Lett; 2016 Dec; 12(6):5289-5294. PubMed ID: 28105237
[TBL] [Abstract][Full Text] [Related]
16. Poly(ADP-ribose) polymerase-1 inhibits ATM kinase activity in DNA damage response.
Watanabe F; Fukazawa H; Masutani M; Suzuki H; Teraoka H; Mizutani S; Uehara Y
Biochem Biophys Res Commun; 2004 Jun; 319(2):596-602. PubMed ID: 15178448
[TBL] [Abstract][Full Text] [Related]
17. [Effect and Mechanism of Radiosensitization of Poly (ADP-Ribose) Polymerase Inhibitor n Lewis Cells and Xenografts].
Wang W; Duan B; Zeng L
Zhongguo Fei Ai Za Zhi; 2016 Jan; 19(1):16-23. PubMed ID: 26805733
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair.
Bryant HE; Helleday T
Nucleic Acids Res; 2006; 34(6):1685-91. PubMed ID: 16556909
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 protects TK6 cells against hydroquinone-induced apoptosis through PARP-1 cytoplasm translocation and stabilizing mitochondrial membrane potential.
Chen Y; Chen S; Liang H; Yang H; Liu L; Zhou K; Xu L; Liu J; Yun L; Lai B; Song L; Luo H; Peng J; Liu Z; Xiao Y; Chen W; Tang H
Environ Mol Mutagen; 2018 Jan; 59(1):49-59. PubMed ID: 28843007
[TBL] [Abstract][Full Text] [Related]
20. Functional interactions of p53 with poly(ADP-ribose) polymerase (PARP) during apoptosis following DNA damage: covalent poly(ADP-ribosyl)ation of p53 by exogenous PARP and noncovalent binding of p53 to the M(r) 85,000 proteolytic fragment.
Kumari SR; Mendoza-Alvarez H; Alvarez-Gonzalez R
Cancer Res; 1998 Nov; 58(22):5075-8. PubMed ID: 9823314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
